Kothari Fermentation & Biochem Q1FY27 Results: Net profit rises to ₹1.63 crore
Kothari Fermentation and Biochem Ltd posted a net profit of ₹162.64 lakh in Q1FY27, reversing a loss of ₹61.23 lakh in Q1FY26. Revenue from operations rose to ₹110.16 lakh. The company also reminded investors of the special window for physical share demat, closing February 4, 2027.

*this image is generated using AI for illustrative purposes only.
Kothari Fermentation and Biochem Ltd reported a net profit of ₹162.64 lakh for the quarter ended June 30, 2026 (Q1FY27), marking a return to profitability from a net loss of ₹61.23 lakh in the corresponding period of FY26. The company also issued its third reminder to shareholders regarding the one-time special window for the transfer and dematerialisation of physical shares, which remains open until February 4, 2027, pursuant to SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026.
The financial results were reviewed by the Audit Committee and approved by the Board of Directors on July 31, 2026. The statutory auditor expressed an unmodified review opinion on the consolidated financial results. These results are prepared in accordance with Indian Accounting Standards (Ind AS) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance Highlights
Revenue from operations surged to ₹110.16 lakh in Q1FY27, compared to ₹26.32 lakh in Q1FY26. Total income, including other income, stood at ₹6,653.59 lakh, driven largely by non-operating sources. Total expenses were ₹6,429.21 lakh, resulting in a profit from operations before exceptional items of ₹224.38 lakh.
| Particulars | Q1FY27 (₹ Lakh) | Q1FY26 (₹ Lakh) | YoY Change |
|---|---|---|---|
| Revenue from Operations | 110.16 | 26.32 | +318.5% |
| Other Income | 6,653.59 | 2,241.18 | +196.9% |
| Total Expenses | 6,429.21 | 2,318.57 | +177.3% |
| Profit Before Tax | 224.38 | (77.39) | Turnaround |
| Net Profit After Tax | 162.64 | (61.23) | Turnaround |
Key Operational Updates
The company allotted 398,800 fully convertible warrants on a preferential basis during the quarter at an issue price of ₹115 per warrant, aggregating to ₹458.62 lakh. Each warrant is convertible into one equity share of face value ₹10 within 18 months from the date of allotment. As of June 30, 2026, no warrants had been converted into equity shares.
Regarding the special window for share transfer, eligible investors are requested to lodge their requests with the company’s RTA, Abhipra Capital Ltd, along with original share certificates and duly executed transfer deeds dated prior to April 1, 2019. Investors are advised to ensure their demat account and KYC details are updated to avoid processing delays.
What the Numbers Show
The significant divergence between revenue from operations (₹110.16 lakh) and total income (₹6,653.59 lakh) indicates that the majority of the company’s income in Q1FY27 was derived from other income rather than core operations. While operational revenue grew substantially year-on-year, the profit before tax of ₹224.38 lakh is heavily influenced by this other income component, suggesting that core operational profitability remains a smaller fraction of the total bottom line.
Historical Stock Returns for Kothari Fermentation & Biochem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.70% | -7.27% | -3.09% | +7.51% | -30.96% | -46.51% |
What specific non-operating activities drove the 196.9% surge in other income, and is this level of income sustainable for future quarters?
How will the conversion of the recently allotted fully convertible warrants impact the company's equity base and earnings per share within the next 18 months?
Given that core operational revenue remains a small fraction of total income, what strategic initiatives are planned to improve profitability from primary business operations?


































